At Last - The Truth About Vitamins.
Vitamins - The Truth’ gives you over 80 pages of Valuable Information on the Foods that supply the Vitamin. At Last - The Truth About Vitamins. -
Bi-layer tablets with sustained release vitaminsMega vitamin & mineral formula Dualtabs Mega Vitamin & Mineral Formula is a revolutionary new concept in multi vitamin and mineral supplementation. Each tablet is composed of one layer of fat soluble vitamins as well as rapid release minerals and digestive aids. The water soluble vitamins are released over a prolonged period of time through the passage in the gastrointestinal tract (digestive tract) for optimum absorption.Dualtabs sustained release bi-layer formula also eliminates the need to take vitamins more than twice daily to achieve peak blood levels of water soluble vitamins over a prolonged period of time. Dualtabs eliminate the interaction between incompatible nutrients for maximum gastric disturbance.VEGETARIAN.
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
Background: Warfarin treatment has a narrow therapeutic range, requiring meticulous monitoring and dosage titration. Individual dosage requirement has recently partly been explained by genetic variation of the warfarin metabolizing enzyme CYP2C9 and the Vitamin K-activating enzyme VKORC1. In the WARIS-II study, comparing three different antithrombotic regimens after myocardial infarction, warfarin treatment reduced thrombotic events, but was associated with more frequent bleeding than use of acetylsalisylic acid (ASA) alone.AimsThe primary aim of the present study was to investigate the relation between genotypes of CYP2C9 and VKORC1 and warfarin maintenance dose in myocardial infarction. The secondary aim was to relate the genotypes to international normalized ratio (INR). Methods: Genotyping was performed in 212 myocardial infarction patients from the WARIS-II study by robotic isolation of DNA from EDTA whole blood (MagNa Pure LC) before PCR amplification (LightCycler) and melting point analysis. Results: The 420 C>T substitution of CYP2C9*2, the 1075 A>C substitution of CYP2C9*3 and the 1173 C>T substitution of VKORC1 had minor allele frequencies of, 11.3%, 5.7% and 36.6% respectively. Warfarin weekly dose varied between 17 mg and 74 mg among the patients. INR did not vary between genotypes. Warfarin dosage requirement was significantly associated with CYP2C9 and VKORC1 genotypes, treatment group and age. The VKORC1 genotype contributed 24.5% to the interindividual variation in warfarin dosage, whereas the combined CYP2C9 genotypes were only responsible for 7.2% of the dose variation. Conclusion: CYP2C9 and VKORC1 genotype frequencies in myocardial infarction patients appear similar to other patient groups and have similar impact on warfarin maintenance dose.
Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits
Background: The objective was to evaluate the effects of rosiglitazone on iliac arteries of hypercholesterolemic rabbits undergoing balloon catheter injury in the contralateral iliac arteries. Methods: White male rabbits were fed a hypercholesterolemic diet for 6 weeks and divided into two groups as follows: rosiglitazone group, 14 rabbits treated with rosiglitazone (3 mg/Kg body weight/day) during 6 weeks; and control group, 18 rabbits without rosiglitazone treatment. All animals underwent balloon catheter injury of the right iliac artery on the fourteenth day of the experiment. Results: There was no significant difference in intima/media layer area ratio between the control group and the rosiglitazone group. Rosiglitazone did not reduce the probability of lesions types I, II, or III (72.73% vs. 92.31%; p = 0.30) and types IV or V (27.27% vs. 7.69%; p = 0.30). There were no differences in the extent of collagen type I and III deposition or in the percentage of animals with macrophages in the intima layer. The percentage of rabbits with smooth muscle cells in the intima layer was higher in rosiglitazone group (p = 0.011). Conclusion: These findings demonstrate that rosiglitazone given for 6 weeks did not prevent atherogenesis at a vessel distant from the injury site.
Daily health Tip: Air Pollution Can Damage Heart, Blood Vessels, Too
Beijing Olympics focuses attention on health problems outside the lungs, researchers say
Leave a Reply
You must be logged in to post a comment.
